News Releases
The latest company news, press releases, and resources about Servier and everything our company has to offer.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
09.22.2025European Commission Approves Servier's VORANIGO® (vorasidenib) as the First Targeted Therapy for Grade 2 IDH-Mutant Glioma in the EU-
09.08.2025Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
-
09.02.2025Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide
-
08.11.2025Servier’s VORANIGO® (vorasidenib) Nominated for 2025 Prix Galien USA Award
-
07.28.2025Servier Announces Positive Data from Long-Term Follow-Up Analysis of the Phase 3 AGILE Trial of TIBSOVO® (ivosidenib) in IDH1-mutated Acute Myeloid Leukemia
Media Contacts
Servier Media Relations
USmediarelations@servier.com